Adolfo Garcia-Sastre

USPTO Granted Patents = 67 (Patent Applications = 39)

CIPO Patents = 8 (Patent Applications = 23)

EPO Patents = 17 (Patent Applications = 48)

Average Co-Inventor Count = 3.2

ph-index = 19

Forward Citations = 1,350(Granted Patents)

Forward Citations (Not Self Cited) = 627(Dec 10, 2025)

Inventors with similar research interests:

Company Filing History:

40 out of 270

Icahn School of Medicine at Mount Sinai

patents

23 out of 242

Mount Sinai School of Medicine

patents

5 out of 260

St. Jude Children's Research Hospital

patents

4. 5 out of 1,195

United States of America, As Represented by the Secretary of Agriculture

patents

5. 5 out of 560

Memorial Sloan Kettering Cancer Center

patents

6. 2 out of 3,539

The United States of America, As Represented by the Secretary, Department of Health and Human Services

patents

7. 1 out of 23

Medimmune Vaccines, Inc.

patents

8. 1 out of 881

University of Kentucky Research Foundation

patents

9. 1 out of 576

The Salk Institute for Biological Studies

patents

10. 1 out of 99

Sanford-burnham Medical Research Institute

patents

11. 1 out of 1,585

Washington University

patents

12. 1 out of 1,457

Rutgers, the State University of New Jersey

patents

13. 3 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Recombinant Newcastle Disease Viruses

Influenza Virus Hemagglutinin Proteins

Chimeric Viruses

Genetically Engineered Swine Influenza Virus

Monoclonal Antibodies

Antiviral Compounds

Influenza Virus Vaccines

Attenuated Negative Strand Viruses

Vaccines for Viral Infections

Influenza Virus Replication

Human Metapneumovirus Disease

Tumor-Associated Antigens

67 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391957 - Recombinant Newcastle disease viruses and uses thereof for the prevention of RSV disease or human metapneumovirus disease (2025-08-19),

2. 12364746 - Mosaic influenza virus hemagglutinin polypeptides and uses thereof (2025-07-22),

3. 12233123 - Influenza virus hemagglutinin proteins and uses thereof (2025-02-25),

4. 12042534 - Newcastle disease viruses and uses thereof (2024-07-23),

5. 12030928 - Anti-influenza B virus neuraminidase antibodies and uses thereof (2024-07-09),

6. 11865173 - Influenza virus hemagglutinin proteins and uses thereof (2024-01-09),

7. 11266734 - Influenza virus hemagglutinin proteins and uses thereof (2022-03-08),

8. 11254733 - Anti-influenza B virus neuraminidase antibodies and uses thereof (2022-02-22),

9. 10736956 - Influenza virus vaccination regimens (2020-08-11),

10. 10583188 - Influenza virus vaccines and uses thereof (2020-03-10),

11. 10544207 - Antibodies against influenza virus hemagglutinin and uses thereof (2020-01-28),

12. 10543268 - Genetically engineered swine influenza virus and uses thereof (2020-01-28),

13. 10308913 - Chimeric viruses presenting non-native surface proteins and uses thereof (2019-06-04),

14. 10251922 - Newcastle disease viruses and uses thereof (2019-04-09),

15. 10179806 - Influenza virus vaccines and uses thereof (2019-01-15),

Title: Innovator Spotlight: Adolfo Garcia-Sastre

Introduction: Adolfo Garcia-Sastre, a prolific inventor based in New York, NY, has made significant contributions in the field of virology with an impressive portfolio of 62 patents. His expertise lies in developing groundbreaking technologies to combat influenza virus, showcasing his commitment to advancing public health through innovative solutions.

Latest Patents: Among his recent patents is the pioneering work on "Influenza virus hemagglutinin proteins and uses thereof." This invention revolves around chimeric hemagglutinin (HA) polypeptides designed to induce a robust immune response against the influenza virus. These patents also encompass methods for generating antibodies to the chimeric HA polypeptides, offering promising avenues for influenza research and vaccine development.

Career Highlights: Adolfo Garcia-Sastre has left a lasting impact through his affiliations with prestigious institutions such as the Icahn School of Medicine at Mount Sinai and the Mount Sinai School of Medicine of New York University. His tenure at these renowned establishments underscores his dedication to advancing scientific knowledge and fostering groundbreaking research in virology.

Collaborations: Throughout his career, Adolfo Garcia-Sastre has collaborated with esteemed professionals in the field, including prominent figures like Peter M Palese and Florian Krammer. These collaborations have not only enriched his research endeavors but also paved the way for innovative discoveries that have the potential to revolutionize the field of virology.

Conclusion: Adolfo Garcia-Sastre's relentless pursuit of innovation and his exceptional contributions to the field of virology exemplify his status as a pioneering inventor. His relentless quest for scientific excellence continues to inspire future generations of inventors and researchers to push the boundaries of knowledge and make a lasting impact on public health worldwide.

This text is generated by artificial intelligence and may not be accurate.